Welcome to LookChem.com Sign In|Join Free

CAS

  • or

202191-13-7

Post Buying Request

202191-13-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

202191-13-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 202191-13-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,1,9 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 202191-13:
(8*2)+(7*0)+(6*2)+(5*1)+(4*9)+(3*1)+(2*1)+(1*3)=77
77 % 10 = 7
So 202191-13-7 is a valid CAS Registry Number.

202191-13-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2-chloroethyl)quinoline-2-carboxamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:202191-13-7 SDS

202191-13-7Downstream Products

202191-13-7Relevant articles and documents

Novel carboxamide derivates salt and use of the same

-

Paragraph 0139-0140; 0180; 0181, (2018/02/10)

The present invention relates to a novel carboxamide derivative salt having mental disorder remedial effects, and uses thereof. The salt as a compound represented by chemical formula 1 or a pharmaceutically allowable salt thereof can treat or prevent mental disorders such as depression, anxiety disorders, panic disorders, obsessive-compulsive disorders, phobias, attention deficit hyperactivity disorder, etc., can increase a remission rate, has fewer side effects and can effectively inhibit reabsorption of serotonin, norepinephrine or dopamine.COPYRIGHT KIPO 2017

Pyridine-oxazoline and quinoline-oxazoline ligated cobalt complexes: Synthesis, characterization, and 1,3-butadiene polymerization behaviors

Guo, Jun,Liu, Heng,Bi, Jifu,Zhang, Chunyu,Zhang, Hexin,Bai, Chenxi,Hu, Yanming,Zhang, Xuequan

, p. 305 - 312 (2015/08/06)

A series of cobalt complexes supported by pyridine-oxazoline (Pyox) and quinoline-oxazoline (Quox) were synthesized. Determined by single crystal X-ray crystallography, complexes 6a and 7c adopted distorted octahedron and trigonal bipyramid geometries, re

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 202191-13-7